The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions

被引:16
|
作者
Atkin, Catherine [1 ]
Reddy-Kolanu, Vinay [2 ]
Drayson, Mark T. [3 ]
Sapey, Elizabeth [1 ]
Richter, Alex G. [3 ]
机构
[1] Univ Birmingham, Inst Inflammat & Ageing, Birmingham Acute Care Res, Birmingham B15 2GW, W Midlands, England
[2] Queen Elizabeth Hosp, Dept Acute Med, Birmingham, W Midlands, England
[3] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
关键词
monoclonal gammopathy of undetermined significance; acute medicine; infection; screening; renal dysfunction; CHAIN DEPOSITION DISEASE; MULTIPLE-MYELOMA; SIGNIFICANCE MGUS; GUIDELINES; MANAGEMENT; RISK; DIAGNOSIS; PROGRESSION; SURVIVAL; THERAPY;
D O I
10.1111/bjh.16487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monoclonal gammopathy of undetermined significance (MGUS) affects 3 center dot 2% of adults aged >50 years. MGUS carries a life-long risk of progression to multiple myeloma and causes complications including infection and renal impairment; common causes of hospital admission. This study aimed to assess MGUS prevalence in emergency medical hospital admissions. Patients were recruited from unselected emergency medical admissions in a hospital in the United Kingdom. Serum protein electrophoresis was performed, with immunofixation of abnormal results. Reason for admission and routine test results were recorded. After education about MGUS and myeloma, patients chose whether they wished to be informed of new diagnoses. A total of 660 patients were tested and 35 had a paraprotein suggestive of MGUS. The overall rate of MGUS was 5 center dot 3%. MGUS prevalence in those aged >50 years was 6 center dot 94%, higher than the previously published rate of 3 center dot 2% (P < 0 center dot 0005). There were higher rates in those with chronic kidney disease (13 center dot 75% vs. 4 center dot 14%, P = 0 center dot 002), heart failure (14% vs. 4 center dot 59%, P = 0 center dot 012), anaemia (8 center dot 96% vs. 3 center dot 41%, P = 0 center dot 003) or leucocytosis (9 center dot 33% vs. 3 center dot 04%, P = 0 center dot 002). In all, 96% of patients wished to be informed of their screening results. The prevalence of MGUS in emergency hospital admissions is higher than expected based on previous population-based rates. This may suggest a selected population for screening.
引用
收藏
页码:1127 / 1135
页数:9
相关论文
共 50 条
  • [31] Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)
    Phull, Pooja
    Sanchorawala, Vaishali
    Connors, Lawreen H.
    Doros, Gheorghe
    Ruberg, Frederick L.
    Berk, John L.
    Sarosiek, Shayna
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2018, 25 (01): : 62 - 67
  • [32] Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects
    Seth, Shivani
    Zanwar, Saurabh
    Vu, Linh
    Kapoor, Prashant
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (02) : 45 - 55
  • [33] Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
    Kyle, Robert A.
    San-Miguel, Jesus F.
    Mateos, Maria-Victoria
    Rajkumar, S. Vincent
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (05) : 775 - +
  • [34] Monoclonal gammopathy of undetermined significance: a new proposal of workup
    Mangiacavalli, Silvia
    Cocito, Federica
    Pochintesta, Lara
    Pascutto, Cristiana
    Ferretti, Virginia
    Varettoni, Marzia
    Zappasodi, Patrizia
    Pompa, Alessandra
    Landini, Benedetta
    Cazzola, Mario
    Corso, Alessandro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 91 (04) : 356 - 360
  • [35] Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism
    Gregersen, Henrik
    Norgaard, Mette
    Severinsen, Marianne T.
    Engebjerg, Malene C.
    Jensen, Paw
    Sorensen, Henrik T.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (02) : 129 - 134
  • [36] Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner, Normann
    Schwaerzler, Angelika
    Goebel, Georg
    Loescher, Wolfgang
    Wanschitz, Julia
    Gunsilius, Eberhard
    ONCOTARGET, 2017, 8 (03) : 5081 - 5091
  • [37] Monoclonal gammopathy of undetermined significance and multiple myeloma
    Schmalzing, M.
    Tony, H. -P.
    Knop, S.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 : 33 - 37
  • [38] Monoclonal gammopathy of undetermined significance: a consensus statement
    Berenson, James R.
    Anderson, Kenneth C.
    Audell, Robert A.
    Boccia, Ralph V.
    Coleman, Morton
    Dimopoulos, Meletios A.
    Drake, Matthew T.
    Fonseca, Rafael
    Harousseau, Jean-Luc
    Joshua, Douglas
    Lonial, Sagar
    Niesvizky, Ruben
    Palumbo, Antonio
    Roodman, G. David
    San-Miguel, Jesus F.
    Singhal, Seema
    Weber, Donna M.
    Zangari, Maurizio
    Wirtschafter, Eric
    Yellin, Ori
    Kyle, Robert A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (01) : 28 - 38
  • [39] Corneal deposits in monoclonal gammopathy of undetermined significance
    Nemeth Orsolya
    Tapaszto Beata
    Tar Sandor
    Szabo Viktoria
    Nagy Zoltan Zsolt
    Toth Jeannette
    Hamed Aryan
    Mikala Gabor
    Szentmary Nora
    ORVOSI HETILAP, 2018, 159 (39) : 1575 - 1583
  • [40] Diagnostic evaluation of monoclonal gammopathy of undetermined significance
    Rajan, Archana M.
    Rajkumar, S. Vincent
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 91 (06) : 561 - 562